Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BRTX
#4934
BioRestorative Therapies, Inc. - Common Stock
0.2
0
USD
-0.05%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-4.76%
Monthly Change
-23.08%
6 month change
0.00%
Year Change
-89.01%
Previous Close
0.2
1
Open
0.2
0
Low
0.2
0
High
0.2
0
Volume
35
Markets
US Stock Market
Healthcare
Biotechnology
BRTX
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2024
Current report, Q3 FY2024
2024.08.13
Biorestorative Therapies, Inc. current report, Q3 FY2024
8-K
Current report, Q3 FY2024
2024.08.06
Biorestorative Therapies, Inc. current report, Q3 FY2024
8-K
Quarterly report, Q2 FY2024
2024.08.13
Biorestorative Therapies, Inc. quarterly report, Q2 FY2024
10-Q
1
2
3
4
News
Alvotech (ALVO) Reports Q2 Loss, Beats Revenue Estimates
Clene Inc. (CLNN) Reports Q2 Loss, Beats Revenue Estimates
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates
What Makes Biorestorative Therapies (BRTX) a New Buy Stock
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Misses Revenue Estimates
Coherus Oncology (CHRS) Reports Q1 Loss, Lags Revenue Estimates
PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates
Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates
Here's Why Biorestorative Therapies (BRTX) Looks Ripe for Bottom Fishing
Biorestorative Therapies, Inc. (BRTX) Reports Q4 Loss, Lags Revenue Estimates
Absci Corporation (ABSI) Reports Q4 Loss, Misses Revenue Estimates
Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates